Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years
Menée aux Etats-Unis, cette étude de cohorte analyse les coûts associés au dépistage du cancer du sein chez des femmes âgées de 40 à 64 ans disposant d'une assurance maladie privée
Over the past decade, screening mammography in the US has undergone notable technological change, as digital breast tomosynthesis (DBT) has replaced 2-dimensional (2D) mammography. Although DBT is more expensive than 2D mammography, DBT may generate downstream savings by reducing the number of women called back for additional imaging. The goal of this cohort study was to characterize changes in breast cancer screening costs as DBT has been adopted at both the patient and population levels.